Activation of plasminogen on the cell surface initiates a cascade of protease activity with important implications for several physiological and pathological events. In particular, components of the plasminogen system participate in tumor growth, invasion and metastasis. Plasminogen receptors are in fact expressed on the cell surface of most tumors, and their expression frequently correlates with cancer diagnosis, survival and prognosis. Notably, they can trigger multiple specific immune responses in cancer patients, highlighting their role as tumor-associated antigens. In this review, three of the most characterized plasminogen receptors involved in tumorigenesis, namely Annexin 2 (ANX2), Cytokeratin 8 (CK8) and alpha-Enolase (ENOA), are analyzed to ascertain an overall view of their role in the most common cancers. This analysis emphasizes the possibility of delineating new personalized therapeutic strategies to counteract tumor growth and metastasis by targeting plasminogen receptors, as well as their potential application as cancer predictors.

Three are better than one: plasminogen receptors as cancer theranostic targets.

CERUTI, PATRIZIA;PRINCIPE, MOITZA;CAPELLO, Michela;CAPPELLO, Paola;NOVELLI, Francesco
2013-01-01

Abstract

Activation of plasminogen on the cell surface initiates a cascade of protease activity with important implications for several physiological and pathological events. In particular, components of the plasminogen system participate in tumor growth, invasion and metastasis. Plasminogen receptors are in fact expressed on the cell surface of most tumors, and their expression frequently correlates with cancer diagnosis, survival and prognosis. Notably, they can trigger multiple specific immune responses in cancer patients, highlighting their role as tumor-associated antigens. In this review, three of the most characterized plasminogen receptors involved in tumorigenesis, namely Annexin 2 (ANX2), Cytokeratin 8 (CK8) and alpha-Enolase (ENOA), are analyzed to ascertain an overall view of their role in the most common cancers. This analysis emphasizes the possibility of delineating new personalized therapeutic strategies to counteract tumor growth and metastasis by targeting plasminogen receptors, as well as their potential application as cancer predictors.
2
1
11
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640925/
plasminogen receptor; theranostic antigen; alpha-enolase; cytokeratin-8; annexin-2; cancer immunotherapy
Ceruti P; Principe M; Capello M; Cappello P; Novelli F.
File in questo prodotto:
File Dimensione Formato  
Ceruti P et al Exp Hematol&Oncol_2013.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 283.75 kB
Formato Adobe PDF
283.75 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/146455
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 33
  • ???jsp.display-item.citation.isi??? ND
social impact